First Quarter 2019 Financial Results and Provides Corporate Update

Moderna Reports First Quarter 2019 Financial Results and Provides ...

Rare Diseases: New development candidate announced for glycogen storage disease type 1a (GSD1a), a rare metabolic disorder; Company now has ...

Portola Pharmaceuticals Reports First Quarter 2019 Financial Results

Cash, cash equivalents and investments at March 31, 2019 totaled $322.8 million, compared with $317.0 million as of December 31, 2018. In March, the Company ...

Agenus Reports First Quarter 2019 Financial Results and Provides ...

Agenus Reports First Quarter 2019 Financial Results and Provides Corporate Update. May 9, 2019. - Gilead partnership yields $150M & first milestone of $7.5M.

Incyte Reports 2019 First Quarter Financial Results and Provides ...

Net income (loss) GAAP net income for the quarter ended March 31, 2019 was $102 million , or $0.48 per basic and $0.47 per diluted share, as compared to net ...

Clearside Biomedical Announces First Quarter 2019 Financial ...

News Release Details. Clearside Biomedical Announces First Quarter 2019 Financial Results and Provides Corporate Update. May 8, 2019. PDF Version. - Scientific ...

Viking Therapeutics Reports First Quarter 2019 Financial Results ...

News & Events. Investors. << Back. Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update. Conference call scheduled for ...

Inpixon Reports First Quarter 2019 Financial Results and Provides ...

PALO ALTO, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Inpixon (NASDAQ: INPX), a leading indoor positioning and data analytics company, today reported ...

Selvita Reports First Quarter 2019 Financial Results and Provides ...

Revenues attributable to non-dilutive grant sources were $1.9 million for the quarter ended March 31, 2019, compared to grant revenues of $1.1 ...

Chimerix Announces First Quarter 2019 Financial Results and ...

... financial results for the first quarter ended March 31, 2019 and provided an update on corporate strategy. Chimerix announced positive top ...

MeiraGTx Reports First Quarter 2019 Financial Results and ...

MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update · $227 million . · $80 million of gross proceeds from a ...

Cellectar Reports First Quarter 2019 Financial Results and Provides ...

FLORHAM PARK, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company ...

Intra-Cellular Therapies Reports First Quarter 2019 Financial ...

Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update. May 8, 2019 at 7:30 AM EDT. PDF Version. NEW YORK , May 08 ...

Adverum Biotechnologies Reports First Quarter 2019 Financial ...

Adverum Biotechnologies Reports First Quarter 2019 Financial Results and Provides Corporate Update · MENLO PARK, Calif. , May 08, 2019 · At the ...

Soleno Therapeutics Provides Corporate Update and Reports First ...

General and administrative expense was $2.0 million for the quarter ended March 31, 2019 , compared to $1.9 million in the same period of 2018. The increase was ...

Proteostasis Therapeutics Reports First Quarter 2019 Financial ...

Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update. News provided by ... 2019 and provided a corporate update ...

Envision Solar Announces First Quarter 2019 Financial Results and ...

The company experienced gross loss of $53,102 during the first quarter of 2019, compared to a gross profit of $34,300 for the period ended March ...

Liquidia Technologies Reports First Quarter 2019 Financial Results ...

Liquidia's management team will host a webcast and conference call at 8:00 a.m. ET today to discuss the financial results and provide a corporate update. The ...

Gilead Sciences Announces First Quarter 2019 Financial Results

(Nasdaq: GILD) announced today its results of operations for the first quarter ended March 31, 2019 . The financial results that follow represent a year-over- ...

argenx reports first quarter 2019 financial results and provides ...

Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep ...

Quarterly Results | Celldex Therapeutics

2024 · Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update · Form 10-Q ...